Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06973772 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Trial to Evaluate the Immunogenicity and Safety of the Co-administration of Live Attenuated Dengue and Chikungunya Vaccines Compared to Separate Administration in Adults Aged 18 to 59 Years.

StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion pushed from Jul 2026 to Jul 2027
    • Start date: Mar 31, 2026 to Mar 31, 2027
    • Study completion pushed from Oct 2026 to Oct 2027
    v3
  2. Start date: Aug 2025 to Mar 31, 2026
    • Publications: details revised at 6 of 7 entries
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This randomized, controlled, double blind trial aims at assessing the safety and immunogenicity profiles of the co-administered Live Attenuated Dengue and Chikungunya vaccines comparatively to the isolated administration, in the adult population aged 18 to 59 years without prior exposure to either arbovirus.
Trial Details
NCT Number NCT06973772
Lead Sponsor Butantan Institute
Conditions
(from sponsor)		 Dengue, Chikungunya
Related terms Chikungunya Fever, Dengue
Enrollment 900 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov